A study on the treatment effects and adverse drug reaction of Metta-osot cannabis oil from medical records in end stage cancer patients received treatment at cannabis clinic. Thai Traditional and Integrated Medicine Hospital ,Bangkok
Keywords:
end stage cancer patients, Metta-osot cannabis oil, the quality of lifeAbstract
This research was conducted for study the treatment effects, adverse reactions and compare the quality of life of patients who received Metta-osot cannabis oil from medical record in end stage cancer at cannabis clinic. The objective of this study was to promote the proper use of cannabis oil. The research method was to collect retrospective data from medical records. There were 274 people received Metta-Osot cannabis oil between August 31 , 2020 – January 30, 2023 , both males and females aged 20-90 years. We collected information from The quality of life data records (EQ - 5D - 5L, ESAS) and adverse drug reaction data records.
The results showed that insomnia, loss of appetite, tiredness/fatigue, sick body/mind nausea and vomiting was significantly improved. Adverse drug reactions were reported in 10 patients (9 %). The most common adverse reaction was dizziness. Therefore, it could be concluded that Metta-Osot cannabis oil would be useful in improving the quality of life for cancer patients in long-term palliative stage and it was safe to some extent. There were limitations in data collection from retrospective research. Therefore, this research may need to be extended for clinical practice in order to increase the credibility of further research.
References
Department of Medical Services. Guidance on the use of medical marijuana.
Bangkok, DMS. 2020
Department of Thai Traditional and Alternative Medicine. Medical practice guidelines for
the use of medical cannabis oil “Metta- osot” and “Karun- osot”. Bangkok, DTAM. 2020
Food and Drug Administration. A manual for the use of the Thai Algorithm in the
assessment of adverse drug reactions from use medicine. Bangkok, FDA. 2022
Waleerat K. Effects and safety of sublingual cannabis oil with 1.7 % THC in
late-stage cancer patients get services at a medical marijuana clinic Chao Phraya
Abhaibhubejhr Hospital. Journal of the Department of Medical Services
; 46 : 50 - 9
Arun B. Consensus recommendations on dosing and administration of
medical cannabis to treat chronic pain : result of a modifies Delphi process. Journal of
Cannabis research 2021;3:22
. Lihi Bar - Lev Schleider . Prospective analysis of safety and efficacy of medical cannabis in
large unselected population of patients with cancer .Euro Journal of Intern Med
; 49 :37 - 43
Anderson R. Behavioral Model of Health Service Use .Journal of Health Society Behaviour
; 36(1):1–10.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Thai Public Health Nurses Association
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ตีพิมพ์และแผนภูมิรูปภาพถือเป็นลิขสิทธิ์ของวารสารพยาบาลสาธารณสุข (Thai Public Health Nurses Association)